TRxADE HEALTH, Inc. Stock

Equities

MEDS

US89846A4058

Internet Services

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
6.5 USD -2.40% Intraday chart for TRxADE HEALTH, Inc. -7.93% +25.09%
Sales 2022 11.45M Sales 2023 8.27M Capitalization 6.48M
Net income 2022 -3M Net income 2023 -17M EV / Sales 2022 0.37 x
Net Debt 2022 450K Net Debt 2023 6.95M EV / Sales 2023 1.62 x
P/E ratio 2022
-0.98 x
P/E ratio 2023
-0.22 x
Employees 34
Yield 2022 *
-
Yield 2023
-
Free-Float 71.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.40%
1 week-7.93%
Current month-36.52%
1 month-31.65%
3 months+54.03%
6 months-1.74%
Current year+25.09%
More quotes
1 week
6.25
Extreme 6.2501
7.68
1 month
6.25
Extreme 6.2501
15.91
Current year
3.69
Extreme 3.69
44.56
1 year
3.69
Extreme 3.69
44.56
3 years
3.69
Extreme 3.69
162.30
5 years
3.69
Extreme 3.69
174.00
10 years
3.69
Extreme 3.69
265.50
More quotes
Managers TitleAgeSince
Founder 49 05-07-14
Chief Executive Officer 53 05-07-14
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 53 05-07-14
Director/Board Member 62 16-08-23
Director/Board Member 66 22-09-29
More insiders
Date Price Change Volume
24-04-22 6.66 +3.58% 28,181
24-04-19 6.43 -7.22% 73,510
24-04-18 6.93 -2.12% 74,297
24-04-17 7.08 +0.28% 51,729
24-04-16 7.06 -3.29% 21,287

Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT

More quotes
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
More about the company